Company
Feldan
Feldan Therapeutics is a clinical-stage biotech company that specializes in the development of treatments based on the intracellular delivery of therapeutics.
Also known as Feldan Therapeutics
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Quebec City, Quebec, Canada
- Legal name
- Feldan Therapeutics
Claim, correct or request removal
Record updated 28 September 2026
About
Feldan is a clinical-stage biotech company that specializes in the development of treatments based on the intracellular delivery of therapeutics. Feldan has developed the Feldan Shuttle®, a proprietary peptide-based technology that enables safe, rapid, and efficient delivery of antisense oligonucleotides (ASO) to cells. This technology unlocks the potential for a new generation of therapeutics by giving access to intracellular targets that are otherwise beyond reach.
Funding snapshot
- Total raised
- $21MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Grant2026-03-12
Funding rounds
- Grant
- 2026-03-12
- Round, 2025
- 2025-02-18
- Series B
- $21M2024-09-04, Company stated
Loading relationship preview